What is required to advance data ethics, data sharing, and Open Science across LMICs

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Choosing wisely: Head and neck cancer

Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN

Intraoperative Radiotherapy

Cancer survivors' stories: An African perspective

Pembrolizumab/carboplatin/paclitaxel combo shows antitumour activity in first-line recurrent/metastatic HNSCC

ESMO 2022: Highlights, commentary and analysis

A new era of early cancer detection with blood test may change cancer screening paradigms

Pembrolizumab with chemoradiation therapy vs placebo plus CRT for locally advanced head and neck squamous cell carcinoma

Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement

New era of early cancer detection blood tests on the horizon